ACADIA HEALTHCARE CO INC (ACHC) Fundamental Analysis & Valuation

NASDAQ:ACHC • US00404A1097

Current stock price

25.95 USD
+0.56 (+2.21%)
Last:

This ACHC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ACHC Profitability Analysis

1.1 Basic Checks

  • ACHC had positive earnings in the past year.
  • ACHC had a positive operating cash flow in the past year.
  • In multiple years ACHC reported negative net income over the last 5 years.
  • ACHC had a positive operating cash flow in each of the past 5 years.
ACHC Yearly Net Income VS EBIT VS OCF VS FCFACHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M -1B

1.2 Ratios

  • ACHC has a Return On Assets of -19.95%. This is in the lower half of the industry: ACHC underperforms 78.00% of its industry peers.
  • ACHC has a worse Return On Equity (-56.58%) than 71.00% of its industry peers.
  • ACHC has a better Return On Invested Capital (6.00%) than 61.00% of its industry peers.
  • ACHC had an Average Return On Invested Capital over the past 3 years of 7.42%. This is in line with the industry average of 8.63%.
Industry RankSector Rank
ROA -19.95%
ROE -56.58%
ROIC 6%
ROA(3y)-5.35%
ROA(5y)-1.32%
ROE(3y)-16.35%
ROE(5y)-6.35%
ROIC(3y)7.42%
ROIC(5y)7.36%
ACHC Yearly ROA, ROE, ROICACHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -20 -40

1.3 Margins

  • ACHC's Operating Margin of 11.71% is amongst the best of the industry. ACHC outperforms 83.00% of its industry peers.
  • In the last couple of years the Operating Margin of ACHC has declined.
  • The Profit Margin and Gross Margin are not available for ACHC so they could not be analyzed.
Industry RankSector Rank
OM 11.71%
PM (TTM) N/A
GM N/A
OM growth 3Y-11.84%
OM growth 5Y-5.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACHC Yearly Profit, Operating, Gross MarginsACHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

2

2. ACHC Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ACHC is destroying value.
  • The number of shares outstanding for ACHC has been reduced compared to 1 year ago.
  • Compared to 5 years ago, ACHC has more shares outstanding
  • The debt/assets ratio for ACHC is higher compared to a year ago.
ACHC Yearly Shares OutstandingACHC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
ACHC Yearly Total Debt VS Total AssetsACHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • ACHC has an Altman-Z score of 1.09. This is a bad value and indicates that ACHC is not financially healthy and even has some risk of bankruptcy.
  • ACHC has a Altman-Z score of 1.09. This is in the lower half of the industry: ACHC underperforms 66.00% of its industry peers.
  • A Debt/Equity ratio of 1.27 is on the high side and indicates that ACHC has dependencies on debt financing.
  • The Debt to Equity ratio of ACHC (1.27) is worse than 65.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Altman-Z 1.09
ROIC/WACC0.73
WACC8.17%
ACHC Yearly LT Debt VS Equity VS FCFACHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B

2.3 Liquidity

  • A Current Ratio of 1.55 indicates that ACHC should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.55, ACHC is in the better half of the industry, outperforming 61.00% of the companies in the same industry.
  • ACHC has a Quick Ratio of 1.54. This is a normal value and indicates that ACHC is financially healthy and should not expect problems in meeting its short term obligations.
  • ACHC has a Quick ratio of 1.54. This is in the better half of the industry: ACHC outperforms 65.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.54
ACHC Yearly Current Assets VS Current LiabilitesACHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

3

3. ACHC Growth Analysis

3.1 Past

  • ACHC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -38.79%.
  • ACHC shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -6.12% yearly.
  • ACHC shows a small growth in Revenue. In the last year, the Revenue has grown by 5.04%.
  • ACHC shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.65% yearly.
EPS 1Y (TTM)-38.79%
EPS 3Y-19.35%
EPS 5Y-6.12%
EPS Q2Q%-89.06%
Revenue 1Y (TTM)5.04%
Revenue growth 3Y8.27%
Revenue growth 5Y9.65%
Sales Q2Q%6.1%

3.2 Future

  • ACHC is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.96% yearly.
  • The Revenue is expected to grow by 6.26% on average over the next years.
EPS Next Y-25.62%
EPS Next 2Y-7.36%
EPS Next 3Y-1.7%
EPS Next 5Y-1.96%
Revenue Next Year3.69%
Revenue Next 2Y4.83%
Revenue Next 3Y5.38%
Revenue Next 5Y6.26%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ACHC Yearly Revenue VS EstimatesACHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B
ACHC Yearly EPS VS EstimatesACHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3

4

4. ACHC Valuation Analysis

4.1 Price/Earnings Ratio

  • ACHC is valuated correctly with a Price/Earnings ratio of 12.85.
  • Based on the Price/Earnings ratio, ACHC is valued cheaper than 86.00% of the companies in the same industry.
  • ACHC's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.21.
  • Based on the Price/Forward Earnings ratio of 17.27, the valuation of ACHC can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ACHC indicates a somewhat cheap valuation: ACHC is cheaper than 69.00% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 23.10, ACHC is valued a bit cheaper.
Industry RankSector Rank
PE 12.85
Fwd PE 17.27
ACHC Price Earnings VS Forward Price EarningsACHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • 78.00% of the companies in the same industry are more expensive than ACHC, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 8.18
ACHC Per share dataACHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-7.36%
EPS Next 3Y-1.7%

0

5. ACHC Dividend Analysis

5.1 Amount

  • No dividends for ACHC!.
Industry RankSector Rank
Dividend Yield 0%

ACHC Fundamentals: All Metrics, Ratios and Statistics

ACADIA HEALTHCARE CO INC

NASDAQ:ACHC (4/8/2026, 11:52:02 AM)

25.95

+0.56 (+2.21%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25
Earnings (Next)04-23
Inst Owners133.62%
Inst Owner Change0%
Ins Owners1.24%
Ins Owner Change1.51%
Market Cap2.39B
Revenue(TTM)3.31B
Net Income(TTM)-1.10B
Analysts74
Price Target23.46 (-9.6%)
Short Float %27.69%
Short Ratio6.36
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)11.79%
Min EPS beat(2)5.25%
Max EPS beat(2)18.32%
EPS beat(4)4
Avg EPS beat(4)12.66%
Min EPS beat(4)5.25%
Max EPS beat(4)18.32%
EPS beat(8)6
Avg EPS beat(8)5.22%
EPS beat(12)10
Avg EPS beat(12)4.68%
EPS beat(16)13
Avg EPS beat(16)10.08%
Revenue beat(2)1
Avg Revenue beat(2)-0.31%
Min Revenue beat(2)-1.28%
Max Revenue beat(2)0.66%
Revenue beat(4)2
Avg Revenue beat(4)-0.26%
Min Revenue beat(4)-1.88%
Max Revenue beat(4)1.45%
Revenue beat(8)2
Avg Revenue beat(8)-1.24%
Revenue beat(12)5
Avg Revenue beat(12)-0.65%
Revenue beat(16)6
Avg Revenue beat(16)-0.64%
PT rev (1m)20.15%
PT rev (3m)8.42%
EPS NQ rev (1m)4.28%
EPS NQ rev (3m)-22.25%
EPS NY rev (1m)0%
EPS NY rev (3m)-27.32%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.19%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)-0.71%
Valuation
Industry RankSector Rank
PE 12.85
Fwd PE 17.27
P/S 0.72
P/FCF N/A
P/OCF 18.14
P/B 1.23
P/tB 4.3
EV/EBITDA 8.18
EPS(TTM)2.02
EY7.78%
EPS(NY)1.5
Fwd EY5.79%
FCF(TTM)-4.77
FCFYN/A
OCF(TTM)1.43
OCFY5.51%
SpS35.93
BVpS21.14
TBVpS6.03
PEG (NY)N/A
PEG (5Y)N/A
Graham Number30.99
Profitability
Industry RankSector Rank
ROA -19.95%
ROE -56.58%
ROCE 7.76%
ROIC 6%
ROICexc 6.16%
ROICexgc 8.63%
OM 11.71%
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-5.35%
ROA(5y)-1.32%
ROE(3y)-16.35%
ROE(5y)-6.35%
ROIC(3y)7.42%
ROIC(5y)7.36%
ROICexc(3y)7.58%
ROICexc(5y)7.53%
ROICexgc(3y)13.72%
ROICexgc(5y)14.49%
ROCE(3y)9.6%
ROCE(5y)9.52%
ROICexgc growth 3Y-18.01%
ROICexgc growth 5Y-2.41%
ROICexc growth 3Y-7.02%
ROICexc growth 5Y2.87%
OM growth 3Y-11.84%
OM growth 5Y-5.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 1.27
Debt/FCF N/A
Debt/EBITDA 4.3
Cap/Depr 302.15%
Cap/Sales 17.26%
Interest Coverage 3.11
Cash Conversion 22.85%
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 1.54
Altman-Z 1.09
F-Score5
WACC8.17%
ROIC/WACC0.73
Cap/Depr(3y)361.37%
Cap/Depr(5y)312.98%
Cap/Sales(3y)17.88%
Cap/Sales(5y)15.11%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-38.79%
EPS 3Y-19.35%
EPS 5Y-6.12%
EPS Q2Q%-89.06%
EPS Next Y-25.62%
EPS Next 2Y-7.36%
EPS Next 3Y-1.7%
EPS Next 5Y-1.96%
Revenue 1Y (TTM)5.04%
Revenue growth 3Y8.27%
Revenue growth 5Y9.65%
Sales Q2Q%6.1%
Revenue Next Year3.69%
Revenue Next 2Y4.83%
Revenue Next 3Y5.38%
Revenue Next 5Y6.26%
EBIT growth 1Y-25.72%
EBIT growth 3Y-4.55%
EBIT growth 5Y3.12%
EBIT Next Year46.21%
EBIT Next 3Y18%
EBIT Next 5Y20.08%
FCF growth 1Y21.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.7%
OCF growth 3Y-29.76%
OCF growth 5Y-25.73%

ACADIA HEALTHCARE CO INC / ACHC Fundamental Analysis FAQ

What is the fundamental rating for ACHC stock?

ChartMill assigns a fundamental rating of 3 / 10 to ACHC.


What is the valuation status for ACHC stock?

ChartMill assigns a valuation rating of 4 / 10 to ACADIA HEALTHCARE CO INC (ACHC). This can be considered as Fairly Valued.


What is the profitability of ACHC stock?

ACADIA HEALTHCARE CO INC (ACHC) has a profitability rating of 3 / 10.


What is the valuation of ACADIA HEALTHCARE CO INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ACADIA HEALTHCARE CO INC (ACHC) is 12.85 and the Price/Book (PB) ratio is 1.23.


What is the financial health of ACADIA HEALTHCARE CO INC (ACHC) stock?

The financial health rating of ACADIA HEALTHCARE CO INC (ACHC) is 2 / 10.